tiprankstipranks
Kura Oncology (KURA)
NASDAQ:KURA
US Market
KURA
Kura Oncology
RESEARCH TOOLSreports
Want to see KURA full AI Analyst Report?

Kura Oncology (KURA) Financial Statements

845 Followers

Kura Oncology Financial Overview

Kura Oncology's market cap is currently $778.45M. The company's EPS TTM is $; its P/E ratio is -3.27; Kura Oncology is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 67.48M$ 53.88M$ 0.00$ 0.00$ 0.00
Gross Profit$ 67.42M$ 53.88M$ -849.00K$ 0.00$ 0.00
Operating Income$ -303.63M$ -193.19M$ -165.80M$ -139.87M$ -131.26M
EBITDA$ -303.63M$ -169.50M$ -150.23M$ -134.85M$ -129.49M
Net Income$ -278.67M$ -173.98M$ -152.63M$ -135.84M$ -130.47M
Balance Sheet
Cash & Short-Term Investments$ 667.24M$ 727.39M$ 423.96M$ 437.99M$ 517.96M
Total Assets$ 738.36M$ 760.16M$ 448.94M$ 456.31M$ 534.05M
Total Debt$ 20.46M$ 16.59M$ 17.20M$ 14.02M$ 6.88M
Net Debt$ -128.64M$ -207.87M$ -20.12M$ -37.78M$ -83.80M
Total Liabilities$ 564.23M$ 346.52M$ 51.66M$ 36.03M$ 27.44M
Stockholders' Equity$ 174.13M$ 413.64M$ 397.27M$ 420.28M$ 506.61M
Cash Flow
Free Cash Flow$ -70.70M$ 133.84M$ -124.99M$ -110.69M$ -105.70M
Operating Cash Flow$ -64.06M$ 134.32M$ -124.82M$ -110.06M$ -104.55M
Investing Cash Flow$ -13.10M$ -101.59M$ 15.56M$ 32.63M$ -126.83M
Financing Cash Flow$ 1.79M$ 154.42M$ 94.78M$ 38.56M$ -3.44M
Currency in USD

Kura Oncology Earnings and Revenue History

Income Statement >

Kura Oncology Debt to Assets

Balance Sheet >

Kura Oncology Cash Flow

Cash Flow >

Kura Oncology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >